Translational Development Acquisition (TDAC) Other Non Operating Income (2024 - 2026)

Translational Development Acquisition (TDAC) has 3 years of Other Non Operating Income data on file, last reported at $1.6 million in Q1 2026.

• Quarterly Other Non Operating Income fell 11.83% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (changed N/A YoY) and the FY2025 annual result came in at $7.3 million, up 5729.44% from the prior year.
• Other Non Operating Income retreated to $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.9 million in Q3 2025 to a low of $125346.0 in Q4 2024.
• A 3-year average of $1.5 million and a median of $1.7 million in 2025 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2025 — Other Non Operating Income soared 1202.7% — and 2026, when it fell 11.83%.
• Tracing TDAC's Other Non Operating Income over 3 years: stood at $125346.0 in 2024, then soared by 1202.7% to $1.6 million in 2025, then fell by 1.16% to $1.6 million in 2026.
• The last three Other Non Operating Income figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.